News for Shilpa Medicare Limited (SHILPAMED.BO)

Stocks including JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin, Biocon, GMR Airports and IRB Infra will be in the spotlight on Monday, March 10.

Shilpa Medicare Limited's Telangana facilities receive EAEU GMP certification, boosting shares on NSE; expanding business in member countries.

BSE Realtys 35% returns are on the back of solid performances by stocks like Anant Raj, Sobha, Oberoi Realty, Prestige Estates and Godrej Properties which have given returns between 178% and 44%.

Stocks including Waaree Energies, GMR Airports Infra, AstraZeneca Pharma, Indus Towers, Ashoka Buildcon, ITI, GVK Power and more will be in the spotlight on Tuesday, November 19.

Shares of Shilpa Medicare will be highlighted as its subsidiary, Shilpa Pharma Lifesciences, obtained a certificate of suitability from European regulators for Desmopressin. This API is used in diabetes treatment. The certification marks a milestone for the company. Shilpa Medicare's stock has increased notably in 2024 despite recent declines.

Stocks including Diffusion Engineers, CESC, Ola Electric, BSE, Bajaj Finance, Bank of Baroda, DMart, Godawari Power and more will be the spotlight on Friday, October 4.

Stocks that will see action today: Buzzing Stocks: BSE, HDFC Bank, RPower, PTC India, BoB, Avenue Supermarts, Bajaj Finance, M&M Financial, Aarti Drugs, Shlpa Medicare, CESC

Indian indices hit new record highs for the third straight session, boosted by the US Fed's rate cut. Analysts remain positive on the market's outlook, with Nifty expected to rise towards 26,200. Support is at 25,700.

Tech Mahindra, Wipro, Infosys, LTIMindtree and TCS were among the top losers on NSE.

Shares of Shilpa Medicare hit a new high of Rs 922, gaining 4% in Monday's intra-day trade after Antique Stock Broking initiate coverage on the stock with a BUY rating and a target price of Rs 1,300.

Jul 08, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good day, and welcome to Shilpa Medicare Limited business update call. (Operator Instructions) Please n

RAICHUR, India, Aug. 28, 2024 /PRNewswire/ -- In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship product, sRbumin® - recombinant human albumin® 20% (rHA), becoming the first Indian company to achieve this milestone. The positive results underscore rHA's potential as a viable alternative to plasma-derived human serum albumin, addressing a critical gap in global healthcare.

Shilpa Medicare Share Price: Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782

Shilpa Medicare, held by Madhusudhan Kela and Sunil Singhania, has returned 45% since its QIP allotment four months ago. Singhania's Abakkus Diversified Alpha Fund-2 received 6 lakh shares, while Kelas Cohesion MK Best Ideas Sub-Trust was allotted 8.79 lakh shares.

Indian stock markets gain momentum with top gainers like JM Financial and Caplin Point Laboratories, showing broad-based participation.

Aug 09, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the Shilpa Medicare earnings call. (Operator Instructions) Please note that th

Landmark Prop, Rail Vikas Nigam, Shilpa Medicare, Marksans Pharma and Ahluwalia Contracts, hit their fresh 52-week highs during the day.

The Nifty Bank index closed 0.83 per cent down at 52660.35.

In the Nifty pack, 36 stocks closed in the green, while 14 stocks ended in the red.